Market News & Insights.

Stifel reiterates Palo Alto Networks stock rating at buy

US homebuilding falls as mortgage rates climb to 7.40%

GBP/USD Eyes 1.3550 as UK Labour Market Shows Signs of Stabilisation

Fed to skip October but raise rates again in December, nearly all economists say: Reuters poll

CHF/JPY Bullish Setup Targets 192.70 as Breakout Pressure Builds

U.S. Housing Starts Dropped Again in September

Housing starts fell 5.2% in September to 1.221 million. Economists had expected a reading of 1.3 million and for starts to rise 2% over the month.

Compass Point reiterates Bullish stock rating citing Bitcoin holdings

Stifel reiterates buy rating on Wyndham Hotels stock

Stifel reiterates Marriott Vacations stock rating on strong lodging

EU NatGas Hits 2022 Crisis Levels As Goldman Warns 150 Euros Could Be Next

EU NatGas Hits 2022 Crisis Levels As Goldman Warns 150 Euros Could Be Next Back in late August, Goldman Sachs commodities expert Samantha Dart warned that EU natural gas prices would need to soar dramatically to discourage Asian LNG demand and shift cargoes to Europe amid…

US single-family housing starts plunge; building permits hit 3-1/2-year low

Kartoon Studios to launch Hundred Acre Wood products on Walmart Marketplace

Stifel cuts Almonty Industries stock price target on shipment delays

Stifel cuts Pool Corp stock price target on margin concerns

Jefferies maintains Underperform on On Holding stock citing margin pressures

Stifel maintains Hold on DXC Technology stock amid unit sale reports

European stocks extend slide as French unrest triggers de-risking

Housing Starts Collapse Near COVID Lows As Homebuilder Confidence Crashes

Housing Starts Collapse Near COVID Lows As Homebuilder Confidence Crashes Following the collapse of Homebuilder confidence (due to mortgage rates, war, and immigration apparently) and the still vast gap down to homebuyer confidence... ...it should be no surprise that…

Stocks Face Uncertainty Ahead of Earnings

Olenox completes $21.7M acquisition of gas, power assets

Pliant Therapeutics appoints Craig Blanchette as SVP, Research

Acrivon advances CDK11 inhibitor for AML, targets 2027 IND filing

AtlasClear signs seventh correspondent broker-dealer agreement

Neurocrine starts phase 2 trial of Alzheimer’s drug candidate

Perma-Pipe secures over $28M in North American orders

First Breach drone prototype reaches 100 mph in testing

Vistagen partners with GATC Health on AI drug development

GMEX investee MediaMeta starts AI dog grooming project in U.S.

Microbot Medical receives patents in U.S., Japan, China, Canada

Jefferies downgrades Zoetis, Elanco on pricing risk; prefers IDEXX